Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cem Meydan

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
The Journal of Experimental Medicine|October 7, 2015
Dose-dependent role of the cohesin complex in normal and malignant hematopoiesisAaron D Viny, Christopher J Ott, Barbara Spitzer, et al.
Haematologica|September 11, 2025
Wild-type p53 overexpression in <i>NPM1</i>-mutated acute myeloid leukemia: potential implications for disease biology and therapy responsePaul D Barone, Siarhei Dzedzik, Ashley S Kleinman, et al.
Nature|March 29, 2021
The spatial landscape of lung pathology during COVID-19 progressionAndré F Rendeiro, Hiranmayi Ravichandran, Yaron Bram, et al.
Nature Immunology|December 13, 2018
Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesisKaterina Hatzi, Huimin Geng, Ashley S Doane, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomasJie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Metabolites|July 26, 2024
A Multiomics, Molecular Atlas of Breast Cancer SurvivorsBrent A Bauer, Caleb M Schmidt, Kathryn J Ruddy, et al.
Research Square|January 16, 2026
Targeted deletion of macrophage ferritin heavy chain protects from macrophage ferroptosis in acute respiratory distress syndromeSuzanne Cloonan, William Zhang, Kihwan Kim, et al.
Cancer Discovery|February 15, 2017
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in <i>IDH2</i>- and <i>TET2</i>-Mutant Acute Myeloid LeukemiaAlan H Shih, Cem Meydan, Kaitlyn Shank, et al.
Cancer Discovery|June 3, 2022
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCLMin Xia, Liron David, Matt Teater, et al.
Cell Reports|November 26, 2020
Multi-omic, Single-Cell, and Biochemical Profiles of Astronauts Guide Pharmacological Strategies for Returning to GravityMonica L Gertz, Christopher R Chin, Delia Tomoiaga, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
The Journal of Experimental Medicine|October 7, 2015
Dose-dependent role of the cohesin complex in normal and malignant hematopoiesisAaron D Viny, Christopher J Ott, Barbara Spitzer, et al.
Haematologica|September 11, 2025
Wild-type p53 overexpression in <i>NPM1</i>-mutated acute myeloid leukemia: potential implications for disease biology and therapy responsePaul D Barone, Siarhei Dzedzik, Ashley S Kleinman, et al.
Nature|March 29, 2021
The spatial landscape of lung pathology during COVID-19 progressionAndré F Rendeiro, Hiranmayi Ravichandran, Yaron Bram, et al.
Nature Immunology|December 13, 2018
Histone demethylase LSD1 is required for germinal center formation and BCL6-driven lymphomagenesisKaterina Hatzi, Huimin Geng, Ashley S Doane, et al.
Biorxiv : the Preprint Server for Biology|February 24, 2023
Cooperative super-enhancer inactivation caused by heterozygous loss of CREBBP and KMT2D skews B cell fate decisions and yields T cell-depleted lymphomasJie Li, Christopher R Chin, Hsia-Yuan Ying, et al.
Metabolites|July 26, 2024
A Multiomics, Molecular Atlas of Breast Cancer SurvivorsBrent A Bauer, Caleb M Schmidt, Kathryn J Ruddy, et al.
Research Square|January 16, 2026
Targeted deletion of macrophage ferritin heavy chain protects from macrophage ferroptosis in acute respiratory distress syndromeSuzanne Cloonan, William Zhang, Kihwan Kim, et al.
Cancer Discovery|February 15, 2017
Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in <i>IDH2</i>- and <i>TET2</i>-Mutant Acute Myeloid LeukemiaAlan H Shih, Cem Meydan, Kaitlyn Shank, et al.
Cancer Discovery|June 3, 2022
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCLMin Xia, Liron David, Matt Teater, et al.
Cell Reports|November 26, 2020
Multi-omic, Single-Cell, and Biochemical Profiles of Astronauts Guide Pharmacological Strategies for Returning to GravityMonica L Gertz, Christopher R Chin, Delia Tomoiaga, et al.
Pageof 12